TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

$283 Million

Synageva Biopharma

Follow-on Offering

Co-Manager, January 2015

Developer of medicines for rare diseases. The company's focus is on developing, delivering and commercializing products for rare diseases.